New drug trial offers hope for Hard-to-Treat bowel disease
Disease control
Recruiting now
This study is testing how well and how safely the drug filgotinib works for Korean adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. It is for people whose symptoms have not been controlled well by standard medications like steroids or other…
Phase: PHASE4 • Sponsor: Eisai Korea Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC